Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial

Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page. A broad set of drug names, chemical classes, and related MeSH terms were removed from the study's indexed terms (examples include Sunitinib, Paclitaxel, pembrolizumab, Nivolumab, Doxorubicin, and Capecitabine).
    Difference
    21%
    Check dated 2026-09-19T20:46:22.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a new build of the study page.
    Difference
    0.0%
    Check dated 2026-08-29T19:39:55.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.6.4 to v3.6.5, indicating a newer build has been deployed. This is a metadata update and does not change the visible content or user functionality.
    Difference
    0.0%
    Check dated 2026-08-08T10:42:58.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The site’s revision metadata was updated from v3.6.3 to v3.6.4, signaling a new page version (no visible content changes are indicated in the provided data).
    Difference
    0.0%
    Check dated 2026-07-25T06:22:44.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a newer version of the ClinicalTrials.gov page. This is a small metadata update that does not modify the study details.
    Difference
    0.0%
    Check dated 2026-07-03T21:46:23.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2, indicating a software version upgrade of the site. This change does not affect the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-27T00:09:47.000Z thumbnail image

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.